Editorial: Translating nanomedicines for anti-cancer treatment
- PMID: 37745078
- PMCID: PMC10515279
- DOI: 10.3389/fphar.2023.1236981
Editorial: Translating nanomedicines for anti-cancer treatment
Keywords: cancer; cancer immunology; cancer immunomodulator; cancer vaccine; imaging and diagnosis; nanomedicine.
Conflict of interest statement
NM was employed by Inimmune Corp. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on the Research Topic Translating nanomedicines for anti-cancer treatment
References
-
- Dasgupta N., Ranjan S., Mishra D., Ramalingam C. (2018). Thermal Co-reduction engineered silver nanoparticles induce oxidative cell damage in human colon cancer cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Chem. Biol. Interact. 295, 109–118. 10.1016/j.cbi.2018.07.028 - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
